U.S. Sex Reassignment Surgery Market (By Gender Transition: Male To Female, Female To Male)- Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

The U.S. sex reassignment surgery market was valued at USD 2.03 billion in 2021 and it is predicted to surpass around USD 5.4 billion by 2030 with a CAGR of 11.48 % from 2022 to 2030.

Growing public acceptance, rising insurance coverage, and increasing medical insight are expected to boost the demand and enhance access to sex reassignment surgeries in the U.S.

Government bodies are implementing measures to expand access to gender reassignment surgery. Health insurance companies and large corporations are increasingly covering gender-altering operations. According to a poll by Willis Towers Watson, a growing number of firms are implementing transgender medical benefits. A federal prisoner in Wisconsin won her lawsuit for gender transition surgery in December 2020, and in May 2021, the Utah Supreme Court upheld the ability of transgender individuals to amend their sex designation on the birth certificate.

The COVID-19 pandemic has drastically affected the market dynamics, with the cancelation of elective procedures, postponement of opted surgeries, and others. The surgical industry is reviving slowly and new surgery inquiries are increasing for gender affirmation surgeries. Plastic surgeons have seen a drastic decrease in the variety of procedures and services they are allowed to offer during the pandemic. Those who conducted primarily gender affirmation, cosmetic, or other regular elective treatments were affected more than those who performed reconstructive, craniofacial, and hand surgery.

Scope of The Report

Gender Transition Insights

Based on gender transition, the market is segmented into male-to-female (MTF) and female-to-male (FTM). The FTM segment dominated the market in 2021 with the largest revenue share. This is attributed to continuous innovations in metoidioplasty, phalloplasty, scrotoplasty, and chest reconstructing. According to ASPS, there was an overall 13% & 14% increase in transgender female sex reassignment surgeries and breast/chest & facial procedures in 2020, respectively.

The MTF sex reassignment surgery is expected to witness the fastest growth during the forecast period owing to the high prevalence of gender dysphoria among males compared to females. According to the 2021 annual report of the Mount Sinai Center for Transgender Medicine and Surgery, around 861 gender-affirming surgeries were performed at this hospital, wherein 639 surgeries were feminization procedures. The transmasculine population aged 25 to 34 is more likely to undergo gender-affirming surgeries, accounting for around 41% of total transfeminine surgeries.

In addition, according to the American Society of Plastic Surgeons, transgender males in the U.S. underwent 9,985 gender confirmation surgeries in 2020 compared to 8,986 in 2019. Government support is also driving the market. Thus, government support in the form of Medicare coverage and an increase in the number of gender confirmation surgeries are factors likely to boost the market growth.

Key Players

• The Mount Sinai Health System
• Transgender Surgery Institute of Southern California
• Cedars Sinai
• Moein Surgical Arts
• Boston Medical Center
• Cleveland Clinic
• CNY Cosmetic & Reconstructive Surgery
• Plastic Surgery Group Rochester
• The University of Michigan Health System
• The Johns Hopkins University

Market Segmentation

By Gender Transition Outlook

• Male-To-Female
• Female-To-Male